Protein Glycosylation: "New-yet-Old" Target for Immunotherapy

Jaydeep Bhat1, Dieter Kabelitz2

  • 1Metabolic Programming, TUM School of Life Sciences Weihenstephan; ZIEL-Institute for Food and Health, Technical University of Munich (TUM), Freising, Germany. bhatvjay24@gmail.com dietrich.kabelitz@uksh.de.

Insights

Checkpoint monotherapy shows limited cancer treatment success. Exploring protein glycosylation, a post-translational modification, offers new targets for effective combined immunotherapy strategies.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Checkpoint monotherapy has shown limited efficacy in cancer treatment.
  • Post-translational modifications (PTMs) like glycosylation play crucial roles in disease pathology.
  • PTMs regulate immunometabolic gene expression, influencing the tumor microenvironment.

Purpose of the Study:

  • To explore the potential of protein glycosylation as a therapeutic target in cancer.
  • To investigate the role of distinct glycosylation patterns in disease.
  • To identify novel mechanistic targets for combined immunotherapy.

Main Methods:

  • Analysis of distinct protein glycosylation patterns in disease states.
  • Investigating the regulatory role of glycosylation in immunometabolic gene expression.
  • Evaluating glycosylation as a target for enhancing immunotherapy.

Main Results:

  • Specific glycosylation patterns are associated with distinct disease characteristics.
  • Glycosylation significantly influences immunometabolic gene expression.
  • Targeting glycosylation presents a promising strategy for combined immunotherapy.

Conclusions:

  • Protein glycosylation is a critical factor in cancer and immune response.
  • Novel therapeutic strategies can be developed by targeting protein glycosylation.
  • Combined immunotherapy approaches targeting glycosylation may overcome limitations of current treatments.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
8.8K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.4K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
4.7K